Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis

Por Sieper, Joachim, van der Heijde, Désirée, Dougados, Maxime, Brown, L Steve, Lavie, Frederic, Pangan, Aileen L
Publicado em 2011